Sponsors: Division of AIDS, US National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health (NIH)
Protocol Summary: To evaluate the safety of BufferGel, a spermicidal microbicide that acidifies semen and maintains the protective acidity of the vagina, in a high-dose trial.
Investigator: Z.M. Chirenje, MD, FRCOG
Location: Spilhaus CRS